Abstract
The Anatomical RecordVolume 304, Issue 12 p. 2904-2904 RetractionFree Access Retraction This article retracts the following: RETRACTED: Alpinumisoflavone suppresses human Glioblastoma cell growth and induces cell cycle arrest through activating peroxisome proliferator-activated receptor-γ Lijuan He, Dong Shen, Jianmei Li, Weidong Mao, Volume 303Issue 11The Anatomical Record pages: 2801-2810 First Published online: January 8, 2020 First published: 27 October 2021 https://doi.org/10.1002/ar.24816AboutSectionsPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat Alpinumisoflavone suppresses human glioblastoma cell growth and induces cell cycle arrest through activating peroxisome proliferator-activated receptor-γ”, by Lijuan HE, Dong SHEN, Jianmei LI, and Weidong MAO. The above article, published in The Anatomical Record (DOI: 10.1002/ar.24350) is retracted by agreement among the authors and the Editor-in-Chief, Dr. Kurt H. Albertine, with notification to the American Association for Anatomy and Wiley Periodicals LLC. The decision is the result of an investigation that revealed issues of scientific integrity in the data that compromise the findings of the paper. REFERENCE He, L., Shen, D., Li, J., & Mao, W. (2020 Nov). Alpinumisoflavone suppresses human Glioblastoma cell growth and induces cell cycle arrest through activating peroxisome proliferator-activated receptor-γ. Anat Rec (Hoboken)., 303(11), 2801– 2810. https://doi.org/10.1002/ar.24350Wiley Online LibraryCASPubMedGoogle Scholar Volume304, Issue12December 2021Pages 2904-2904 ReferencesRelatedInformation
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
